These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


290 related items for PubMed ID: 7697909

  • 1. Immunomodulation of autoimmunity in MRL/lpr mice with syngeneic bone marrow transplantation (SBMT).
    Karussis DM, Vourka-Karussis U, Lehmann D, Abramsky O, Ben-Nun A, Slavin S.
    Clin Exp Immunol; 1995 Apr; 100(1):111-7. PubMed ID: 7697909
    [Abstract] [Full Text] [Related]

  • 2. Progress toward production of immunologic tolerance with no or minimal toxic immunosuppression for prevention of immunodeficiency and autoimmune diseases.
    Good RA.
    World J Surg; 2000 Jul; 24(7):797-810. PubMed ID: 10833246
    [Abstract] [Full Text] [Related]

  • 3. Bone marrow transplantation: a new strategy for intractable diseases.
    Ikehara S.
    Drugs Today (Barc); 2002 Feb; 38(2):103-11. PubMed ID: 12532188
    [Abstract] [Full Text] [Related]

  • 4. A new strategy for treatment of autoimmune diseases in chimeric resistant MRL/lpr mice.
    Takeuchi K, Inaba M, Miyashima S, Ogawa R, Ikehara S.
    Blood; 1998 Jun 15; 91(12):4616-23. PubMed ID: 9616158
    [Abstract] [Full Text] [Related]

  • 5. Combined effects of FK506 (tacrolimus) and cyclophosphamide on atypical B220+ T cells, cytokine gene expression and disease activity in MRL/MpJ-lpr/lpr mice.
    Woo J, Wright TM, Lemster B, Borochovitz D, Nalesnik MA, Thomson AW.
    Clin Exp Immunol; 1995 Apr 15; 100(1):118-25. PubMed ID: 7535208
    [Abstract] [Full Text] [Related]

  • 6. Prevention of experimental autoimmune encephalomyelitis and induction of tolerance with acute immunosuppression followed by syngeneic bone marrow transplantation.
    Karussis DM, Slavin S, Lehmann D, Mizrachi-Koll R, Abramsky O, Ben-Nun A.
    J Immunol; 1992 Mar 15; 148(6):1693-8. PubMed ID: 1541813
    [Abstract] [Full Text] [Related]

  • 7. Effective treatment of autoimmune disease and progressive renal disease by mixed bone-marrow transplantation that establishes a stable mixed chimerism in BXSB recipient mice.
    Wang B, Yamamoto Y, El-Badri NS, Good RA.
    Proc Natl Acad Sci U S A; 1999 Mar 16; 96(6):3012-6. PubMed ID: 10077628
    [Abstract] [Full Text] [Related]

  • 8. Prevention of autoimmune hearing loss in MRL/lpr mice by bone marrow transplantation.
    Lee S, Iwai H, Sugiura K, Takeuchi K, Kushida T, Tomoda K, Inaba M, Yamashita T, Ikehara S.
    Bone Marrow Transplant; 2000 Oct 16; 26(8):887-92. PubMed ID: 11081390
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment of autoimmune diseases in MRL/lpr mice by allogenic bone marrow transplantation plus adult thymus transplantation.
    Hosaka N, Ryu T, Miyake T, Cui W, Nishida T, Takaki T, Inaba M, Ikehara S.
    Clin Exp Immunol; 2007 Mar 16; 147(3):555-63. PubMed ID: 17302907
    [Abstract] [Full Text] [Related]

  • 11. Treatment of intractable autoimmune diseases in MRL/lpr mice using a new strategy for allogeneic bone marrow transplantation.
    Kushida T, Inaba M, Takeuchi K, Sugiura K, Ogawa R, Ikehara S.
    Blood; 2000 Mar 01; 95(5):1862-8. PubMed ID: 10688849
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. New strategies for BMT, organ transplantation, and regeneration therapy.
    Ikehara S.
    Hematology; 2003 Apr 01; 8(2):77-81. PubMed ID: 12745656
    [Abstract] [Full Text] [Related]

  • 16. Beneficial effects of bone marrow transplantation on the serological manifestations and kidney pathology of experimental systemic lupus erythematosus.
    Levite M, Zinger H, Zisman E, Reisner Y, Mozes E.
    Cell Immunol; 1995 Apr 15; 162(1):138-45. PubMed ID: 7704902
    [Abstract] [Full Text] [Related]

  • 17. Autoimmunity in mice bearing lprcg: a novel mutant gene.
    Kimura M, Matsuzawa A.
    Int Rev Immunol; 1994 Apr 15; 11(3):193-210. PubMed ID: 7930845
    [Abstract] [Full Text] [Related]

  • 18. Treatment of autoimmune MRL/Mp-lpr/lpr mice with cholera toxin.
    Fan JL, Himeno K, Tsuru S, Nomoto K.
    Clin Exp Immunol; 1987 Oct 15; 70(1):94-101. PubMed ID: 3500817
    [Abstract] [Full Text] [Related]

  • 19. Effects of FTY720 in MRL-lpr/lpr mice: therapeutic potential in systemic lupus erythematosus.
    Okazaki H, Hirata D, Kamimura T, Sato H, Iwamoto M, Yoshio T, Masuyama J, Fujimura A, Kobayashi E, Kano S, Minota S.
    J Rheumatol; 2002 Apr 15; 29(4):707-16. PubMed ID: 11950011
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 15.